New treatment Xadago to help 100,000 Canadians living with Parkinson’s

News

Author: Parkinson's Life editorsPublished: 5 May 2017

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

More than 100,000 Canadians living with Parkinson’s will benefit from a new product to be launched in the country.

The drug known as ‘Xadago’, currently readily available in several countries across Europe, helps control motor symptoms and complications over a 24-month period.

Xadago will be the first new oral treatment for Parkinson’s in almost 15 years in Canada. On 21 March 2017 the Food and Drug Administration in the US approved the use of Xadago for the treatment of Parkinson’s as an add-on therapy to levodopa/carbidopa.

Go Back

Share this story

Comments


Related articles


PD in Practice

Which physiotherapy treatment is right for you?

Physiotherapy guidelines reveal best treatments – including Tai Chi

READ MORE
Parkinson's

Interviews

Fynlee Hateley: the 13-year-old Parkinson’s campaigner

The boy has raised UK £1,000 for the condition

READ MORE
Billy Connolly Meryvn Peake Awards

Europe

9 stunning works of art created by people with Parkinson’s

A special gallery in London will showcase the artworks

READ MORE